A deficiency in CCR2+ monocytes: the hidden side of Alzheimer's disease
- PMID: 23892208
- DOI: 10.1093/jmcb/mjt028
A deficiency in CCR2+ monocytes: the hidden side of Alzheimer's disease
Abstract
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by intracellular neurofibrillary tangle formation and extracellular amyloid-β (Aβ) deposition. To date, microglia seem to act as double-edged swords, being either beneficial (e.g. clearance of Aβ) or detrimental (e.g. secretion of neurotoxic factors) in AD. Following a rather intense debate on the question, a consensus has emerged that microglia can renew themselves via proliferation of already differentiated microglia as well as via the de novo recruitment of monocytes of mouse models of AD. However, recent advances suggest distinct function for resident and bone marrow-derived microglia (BMDM), and have emphasized the neuroprotective functions of BMDM. BMDM is the only subset of cells that restrict cerebral amyloidosis in the AD brain, which has been recently attributed to CCR2(+) monocytes. Moreover, an impaired recruitment of CCR2(+) monocytes has been reported in AD patients, as seen from the CCR2(+) monocytopenia found in the bloodstream and BM. The present review summarizes the current knowledge on the roles and dysfunctions of CCR2(+) monocytes in AD and their potential as key therapeutic targets.
Keywords: Alzheimer's disease; CCR2; CX3CR1; M-CSF; bone marrow-derived microglia; cytokines; monocytes.
Similar articles
-
Mechanisms of microglia accumulation in Alzheimer's disease: therapeutic implications.Trends Pharmacol Sci. 2008 Dec;29(12):626-32. doi: 10.1016/j.tips.2008.08.004. Epub 2008 Oct 1. Trends Pharmacol Sci. 2008. PMID: 18835047 Review.
-
Monocytes and Alzheimer's disease.Neurosci Bull. 2011 Apr;27(2):115-22. doi: 10.1007/s12264-011-1205-3. Neurosci Bull. 2011. PMID: 21441973 Free PMC article. Review.
-
The role and therapeutic potential of monocytic cells in Alzheimer's disease.Glia. 2010 Jun;58(8):889-900. doi: 10.1002/glia.20973. Glia. 2010. PMID: 20155817 Review.
-
Stromal cell-derived factor 1α decreases β-amyloid deposition in Alzheimer's disease mouse model.Brain Res. 2012 Jun 12;1459:15-26. doi: 10.1016/j.brainres.2012.04.011. Epub 2012 Apr 17. Brain Res. 2012. PMID: 22560596
-
Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease.Nat Med. 2007 Apr;13(4):432-8. doi: 10.1038/nm1555. Epub 2007 Mar 11. Nat Med. 2007. PMID: 17351623
Cited by
-
Platelet dysfunction in hypercholesterolemia mice, two Alzheimer's disease mouse models and in human patients with Alzheimer's disease.Biogerontology. 2015 Aug;16(4):543-58. doi: 10.1007/s10522-015-9580-1. Epub 2015 May 7. Biogerontology. 2015. PMID: 25947203 Free PMC article.
-
High fat diet exacerbates Alzheimer's disease-related pathology in APPswe/PS1 mice.Oncotarget. 2016 Oct 18;7(42):67808-67827. doi: 10.18632/oncotarget.12179. Oncotarget. 2016. PMID: 27661129 Free PMC article.
-
Inflammation after Ischemic Stroke: The Role of Leukocytes and Glial Cells.Exp Neurobiol. 2016 Oct;25(5):241-251. doi: 10.5607/en.2016.25.5.241. Epub 2016 Oct 26. Exp Neurobiol. 2016. PMID: 27790058 Free PMC article. Review.
-
Complex role of chemokine mediators in animal models of Alzheimer's Disease.Biomed J. 2018 Feb;41(1):34-40. doi: 10.1016/j.bj.2018.01.002. Epub 2018 Mar 27. Biomed J. 2018. PMID: 29673550 Free PMC article. Review.
-
Targeting brain-peripheral immune responses for secondary brain injury after ischemic and hemorrhagic stroke.J Neuroinflammation. 2024 Apr 18;21(1):102. doi: 10.1186/s12974-024-03101-y. J Neuroinflammation. 2024. PMID: 38637850 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
